RecruitingNot ApplicableNCT04207814

Determinants of Repeated Spontaneous Miscarriages and Unexplained Fetal Deaths

Determinants of Repeated Spontaneous Miscarriages and Unexplained Fetal Deaths (DEFI-2)


Sponsor

University Hospital, Brest

Enrollment

200 participants

Start Date

Oct 5, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The DEFI-1 study recruited 625 women witnesses and 299 of their spouses. With regard to case couples, 271 cases were recruited from the spontaneous repeated miscarriages (SRM) subgroup (≥3 spontaneous miscarriage (SM) from trimester 1 of pregnancy) and 93 from the unexplained fetal death in utero (FDIU) subgroup from trimesters 2 and 3 of pregnancy. The main objective of the DEFI 2 study is to increase the number of case-pairs in these 2 particular subgroups to replicate the results of the genetic determinants highlighted from cases and controls with extreme phenotypes and obtain a sufficient number of women with FDIUs to identify specific determinants.


Eligibility

Min Age: 18 YearsMax Age: 40 Years

Inclusion Criteria5

  • couples whose wife is over 18 and under 40 inclusive,
  • couples having undergone at least 3 unexplained SM in the first trimester or an FDIU in the trimesters 2 and 3 of pregnancy (excluding funicular and fetal causes and proven preeclampsia)
  • the man must be over 18 years old.
  • each member of the couple must consent to the investigation.
  • Subjects benefiting from a social security scheme.

Exclusion Criteria9

  • couples where the woman is under 18 or over 40,
  • couples whose man is under 18,
  • identified cause of SRM or FDIU
  • Inability to consent for one of the members of the couple,
  • refusal to participate for one of the members of the couple.
  • treatment with anticoagulants or anti-aggregating platelet for women.
  • Person under legal protection
  • Subjects not benefiting from a social security scheme
  • Refusal to participate

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALbiological sample

biological samples will be taken from the subjects included


Locations(1)

BREST

Brest, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04207814